spacer
home > ebr > winter 2018 > gut feeling
PUBLICATIONS
European Biopharmaceutical Review

Gut Feeling

Vaccination is one of the most efficient and cost-effective medical interventions that exist. Being healthy is the most important thing in life, and preventing illness is something to strive for. Diarrhoeal diseases, respiratory infections, malaria, HIV/AIDS and tuberculosis are infectious diseases that globally harvest the most casualties, with the deaths of over 1 million children under the age of five caused by diarrhoea-contracted diseases alone every year.

Vaccination has made an enormous contribution to global health. Immunisation saves 2-3 million deaths every year from diphtheria, tetanus, pertussis and measles. However, an additional 1.5 million deaths could be avoided if global vaccination coverage improves. Despite these successes, approximately 7 million children still die each year, and about a half of these mortalities are caused by infections, which could be prevented by vaccination.

Several aspects of health economics should be considered for vaccines. The benefits of vaccination extend beyond prevention of specific diseases in individuals, enabling a rich, multifaceted harvest for societies and nations. It also makes good economic sense and meets the need to care for the weakest members of society. Reducing global child mortality rates by facilitating universal access to safe vaccines of proven efficacy is a moral obligation for the international community as a human right exists for every individual to have the opportunity to live a fuller, healthier life.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Björn Sjöstrand is the founder and Chief Executive Officer at Scandinavian Biopharma. He has extensive experience in the vaccine industry and has held many executive positions in Swedish and international companies. Björn has held positions including Chief Executive Officer of SBL Vaccines, Chief Executive Officer at Berna Biotech AG, Chief Business Officer at Crucell NV, Non-Executive Director at European Vaccine Manufacturers and a member of the Global Alliance for Vaccination and Immunisation. He also holds several board positions in both private and public companies and has been an advisor to the Bill and Melinda Gates Foundation.
spacer
Björn Sjöstrand
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a leading organization working to support the diagnosis and treatment of Parkinson’s disease (PD). Since 2011, Charles River and MJFF have worked together to accelerate the discovery of therapies for PD. This latest extension includes grants from MJFF to support two projects:
More info >>

White Papers

7 Common Myths about QP Training Debunked: A Guide for Senior Managers

RSSL

The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >>

 
Industry Events

Outsourcing in Clinical Trials Medical Device USA 2018

11-12 July 2018, Minneapolis, Minnesota

6th Outsourcing in Clinical Trials conference is the only clinical outsourcing platform for medical device companies within Medical Alley this year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement